| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |